A Study to Understand the Genetics and Clinical Course of Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN)
Public ClinicalTrials.gov record NCT04235621. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study to Characterize the Genetic, Biomarker, and Clinical Profile of Patients With Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a study with 2 parts. Part 1 comprises a visit to collect biological samples necessary for the molecular characterization of chronic kidney disease. Part 2 comprises an observational period of 5 visits over a period up to 8 weeks. During Part 2, baseline tests will be conducted, and urine will be collected approximately every 2 weeks for 8 weeks. Patients may participate in Part 1, Part 2, or both, and will be followed for up to 1 year consisting of data collection from the patient's medical records and home collection of urine samples every 4 months.
Study identification
- NCT ID
- NCT04235621
- Recruitment status
- Terminated
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 20 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 20, 2019 (Actual)
- Primary completion
- May 27, 2020 (Actual)
- Completion
- May 27, 2020 (Actual)
- Last update posted
- Jul 20, 2021
2019 – 2020
United States locations
- U.S. sites
- 18
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Aventiv Research - Phoenix | Mesa | Arizona | 85210-6041 | — |
| Glendale Adventist Medical Center | Glendale | California | 91206 | — |
| DaVita Mojave Sage Dialysis | Victorville | California | 92395-8322 | — |
| Colorado Kidney Care | Denver | Colorado | 80230-7200 | — |
| Renal and Transplant Associates of New England, PC | Springfield | Massachusetts | 01107-1369 | — |
| St. Clair Nephrology | Roseville | Michigan | 48066 | — |
| DaVita Clinical Research | Minneapolis | Minnesota | 55404-1212 | — |
| Clinical Research Consultants | Kansas City | Missouri | 64111 | — |
| DaVita Pelican Point Dialysis | Las Vegas | Nevada | 89129-6201 | — |
| High Desert Nephrology | Gallup | New Mexico | 87301-5655 | — |
| Akron Nephrology Associates, Inc. | Akron | Ohio | 44302-1715 | — |
| Southeast Renal Research Institute | Chattanooga | Tennessee | 37404-2743 | — |
| Arlington Nephrology, PC | Arlington | Texas | 76015 | — |
| North Texas Kidney Disease Association | Lewisville | Texas | 75057-6039 | — |
| South Texas Renal Care Group (Downtown) | San Antonio | Texas | 78207 | — |
| San Antonio Kidney Disease Center Physicians Group (Wurzbach Road) | San Antonio | Texas | 78229-3809 | — |
| South Texas Renal Care Group (Westover Hills) | San Antonio | Texas | 78251-1230 | — |
| San Antonio Kidney Disease Center Physicians Group (Carnoustie Drive) | San Antonio | Texas | 78258-4800 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04235621, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 20, 2021 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04235621 live on ClinicalTrials.gov.